"...it is clear that there are people who use marijuana solely to ameliorate symptoms associated with chronic disease, such as HIV/AIDS. This suggests that cannabinoids have potential benefit as a therapeutic class of agents." (02/04)

 Key Experts
Physicians [We believe physicians are the "key experts" in the medical marijuana debate because the issue is thought by many to be ultimately based on the medical value and risks of marijuana, and Physicians, with their training and clinical work, should (at least in theory) have the best knowledge of marijuana's medical value and risks.].

• 1997 - Present - Co-Director, Diagnostic Virology Laboratory, Stanford University
• 1997 - Present - Assoc. Medical Director, Stanford University AIDS Clinical Trial Group
• 1997 - Present - Associate Professor, Division of Infectious Diseases, Stanford University

• 1983 - Fellowship, Infectious Diseases, University of California, Davis
• 1981 - Fellowship, Infectious Diseases, University of California, San Diego
• 1980 - Residency, Internal Medicine, University of Davis
• 1981 - Fellowship, Infectious Diseases, University of California, San Diego
Davis
• 1978 - Internship, Internal Medicine, University of New Mexico
• 1977 - M.D., University of California, San Diego
• 1972 - B.A., University of California, San Diego

• 2000 -- Doris Duke Distinguished Clinical Scientist Award. Affordable Feasible Treatment for HIV infected Women in Southern Africa